Nuvation Bio Inc. (NUVB) Return on equity 2023–2025
Nuvation Bio Inc. (NUVB) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-66.9%FY2025 · since FY2023: -12.5% → -66.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -66.9% | +55.5 pp |
| FY2024 | -122.5% | -109.9 pp |
| FY2023 | -12.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice